Cluster Headache Research

For decades, the medical community largely overlooked cluster headache. Clusterbusters exists in large part to change that. Since our founding in 2002 by Robert Wold, advancing research for this condition has been central to our mission, working with leading institutions to better understand cluster headache and to develop and improve treatment options for the patient community.

Over the years, our research and collaboration efforts have grown to include partnerships with institutions such as Harvard, Yale, Hannover Medical School in Germany, the Veterans Administration and Children's Hospital, studying the many impacts of cluster headache on the people who live with it. Much of this work has been completed and published, and you can read it in our Past Research section.

With the help of Dr. Larry Schor at the University of West Georgia, we were able to complete the largest survey ever conducted to establish the severity and burden of cluster headache. Work like this matters because cluster headache patients and advocates have helped move this condition toward the forefront of headache research, giving hope to people who do not respond to current treatments.

We have a number of ongoing research projects, organized into open and closed trials and surveys.  These areas of study are essential to cluster headaches for countless reasons, mainly because the medical community largely ignored this disease for decades. Clusterbusters and cluster headache patient advocates have helped move this condition to the forefront of headache research, giving hope to those who don’t respond to current treatment options for future pain relief.  You can learn more about our partnerships and affiliations with educational institutions and nonprofit organizations.

How to Get Involved with Cluster Headache Research

If you are an episodic or chronic cluster headache patient and want to get involved, we encourage you to sign up for our Patient Registry. The registry allows us to connect patients with current research and trials in their area, including studies worldwide. We have had real success filling spots for clinical trials in the past, including the CGRP antibody trials that led to FDA approval of Emgality, the first medication explicitly approved for episodic cluster headache.

ClinicalTrials.gov is another excellent resource for finding recruiting studies for your condition, with information on how to contact the researchers directly. You can also support this work by donating directly to research through Clusterbusters.

Doctors, scientists, psychologists, and others interested in researching cluster headache can reach us through our contact form.

Research Library

A collection of published research on cluster headache and its treatment. Use the topic groups below to browse. Each entry summarizes what the study asked and found in plain language. Links lead to the published source; access may vary by journal. If you need access to a specific study, contact us.

Abortive (Acute) Treatment Research

Reference ID: TRT35 (2009)
Breathing pure oxygen through a mask at the first sign of an attack stopped the pain for most people within 15 minutes, with no real side effects.  High-flow oxygen can shut down an attack quickly, but it only works well if the flow rate is high enough and you use the right kind of mask. Getting the equipment right is the difference between oxygen working and seeming useless. This is the strongest evidence we have that oxygen works, and it is a big reason oxygen is considered a first-choice treatment.

Reference ID: TRT20 (2017)
Confirms that inhaled oxygen is a safe and effective way to stop cluster attacks and belongs in most people's treatment plan.

Reference ID: TRT28 (2017)
A guide for doctors on how to actually write an oxygen prescription that works, including the flow rate, mask, and paperwork patients need. It exists because oxygen is proven to help, yet many patients still struggle to get a proper setup.

Reference ID: TRT18
Patients reported on their own real-world experience with oxygen, and the takeaway is that it helps a great many people, though access and equipment are common hurdles.

Reference ID: TRT14 (2016)
An overview of the ways to stop an attack once it has started, pointing to oxygen and fast-acting triptan injections as the options with the best track record.

Reference ID: TRT34 (2019)
A look at the treatments used to abort attacks, concluding that oxygen and injectable triptans are the most dependable when used early.

Preventive & pharmacologic treatment

Reference ID: TRT13 (2013)
A broad summary of the medications used to prevent and treat cluster headache, useful for understanding the full range of drug options and roughly how well each is supported.

Reference ID: TRT21 (2016)
A wider overview of medications used for headache disorders generally, with cluster headache included among them.

Reference ID: TRT19 (2007)
Clomiphene, a drug that affects hormone levels, helped some patients with hard-to-treat chronic cluster headache, offering another avenue when the usual preventives have failed. (Small/early evidence.)

Reference ID: TRT30 (2011)
The blood thinner warfarin reduced attacks in some people with chronic cluster headache that had resisted everything else, an unusual option worth knowing about for the most stubborn cases. (Small/early evidence.)

Reference ID: TRT39 (2003)
Examines dopamine-related medications as a treatment route, adding to the understanding of which drugs may help and what is happening in the brain during cluster headache. This paper suggests that dopamine agonists exacerbate rather than relieve headaches associated with microprolactinomas, indicating that alterations in the dopamine-prolactin axis and hypothalamic dysfunction drive these attacks. Consequently, dopamine agonists are not supported as a helpful treatment route for cluster headache or related syndromes in these cases, whereas somatostatin analogues and indomethacin provide relief.

Diagnosis, classification & related conditions

Reference ID: TRT4 (2013)
This systematic review by Viana et al. (published in The Journal of Headache and Pain, 2013) evaluated 22 studies comprising 2,614 patients. It concluded that diagnostic delays, misdiagnoses, and improper/invasive treatments are highly frequent in patients with trigeminal autonomic cephalalgias and hemicrania continua, underscoring the urgent need for better medical education among both primary care physicians and specialists.

Reference ID: TRT6
A trusted, comprehensive summary of how to treat cluster headache, covering the main acute, short-term, and preventive options and when each is used. A solid starting point for understanding the standard of care.

Reference ID: TRT31 (2010)
A clear primer on spotting and treating cluster headache, helpful for understanding what a sound diagnosis and treatment plan look like.

Reference ID: TRT5 (2010)
Explains that cluster headache belongs to a small family of related one-sided headache conditions, and that telling them apart matters because they are treated differently.

Reference ID: TRT26 (2004)
Reviews how to treat that family of related headache conditions, with the practical point that matching the treatment to the exact diagnosis is what gets results.

Reference ID: TRT27 (2006)
Describes two rare headache conditions that can look like cluster headache, helping explain why an accurate diagnosis sometimes takes time and a specialist.

Reference ID: TRT9 (2001)
Hypnic headache may follow a remitting-relapsing pattern susceptible to circadian rhythm disruption (such as travel across time zones), supporting the hypothesis that it is a chronobiological disorder.

Reference ID: TRT41 (2007)
Points out that cluster headache does not always center on the eye and can sometimes involve the back of the head, which can lead to it being missed or misdiagnosed.

Reference ID: TRT40 (2005)
A reminder that a tumor on the pituitary gland can cause headaches that mimic cluster headache, which is why doctors sometimes order brain imaging to rule out other causes.

Reference ID: CHR4 (2016)
A general overview of cluster headache, covering symptoms, attack patterns, and treatment options. A good starting point for anyone new to the condition.

Reference ID: CHR5 (2011)
A large survey of people with cluster headache in the United States, describing who gets it, how attacks behave, and how the condition affects daily life.

Reference ID: CHR14 (2007)
Estimates how many people in Germany live with cluster headache, adding to what we know about how common the condition is.

Reference ID: CHR17 (2005)
Describes the typical features of cluster headache attacks, including where the pain is, when it strikes, and the symptoms that come with it. This helps doctors recognize the condition.

Reference ID: CHR20 (2008)
Combines data from many studies to look at how often cluster headache occurs in men compared with women.

Reference ID: CHR30 (2001)
Looks at how cluster headache differs between men and women, which can help reduce misdiagnosis in women.

Treatment reviews, dilemmas & updates

Reference ID: TRT32 (2007)
Walks through the tough decisions in treating cluster headache, especially how to help patients who do not respond to standard treatments and how to weigh relief against side effects.

Reference ID: TRT33 (2013)
Summarizes what has recently changed in cluster headache treatment, including newer therapies, useful for seeing how options are expanding.

Reference ID: TRT42 (2008)
Explains that using attack-stopping medication too often can actually cause more headaches over time, and offers guidance on avoiding that trap. Relevant to anyone leaning heavily on acute medication.

Reference ID: TRT22 (2003)
Explains why some people improve on a placebo treatment in studies, which is important background for judging whether a treatment truly works rather than just seeming to.

Reference ID: CHR2 (2016)
Traces how doctors have understood and described cluster headache over time, from early accounts to today.

Reference ID: CHR7 (1997)
Guidelines for researchers on how to design high-quality clinical trials for cluster headache, so results are reliable and can be compared across studies.

Burden, psychology & quality of life

Reference ID: TRT23 (200)
Looks at the emotional and mental health toll of living with chronic headache, affirming that the psychological weight is real and deserves care alongside the physical pain.

Reference ID: TRT24 (2006)
Examines the relationship between cluster headache and sexual activity, which for some people can trigger an attack and for others can relieve one. While sexual activity can trigger attacks in some individuals, it can also provide immediate and complete relief from an active cluster headache episode upon reaching orgasm, likely due to hypothalamic modulation, endorphin release, or increased sympathetic activity.

Reference ID: TRT25 (2018)
Inhaled oxygen at flow rates >10 L/min and injectable sumatriptan demonstrate comparable efficacy in the acute treatment of cluster headache. High-flow oxygen represents a safe, highly effective alternative that avoids the dosing limitations and patient-reported side effects associated with triptan medications.

Reference ID: CHR33 (2021)

Found that demoralization, a deep sense of hopelessness and loss of purpose, was a strong warning sign for suicidal thoughts in people with cluster headache. It shows why emotional support matters as much as pain relief.

Ketamine

Reference ID: TRT10 (2019)
Ketamine, a hospital anesthetic, shows early promise for easing cluster pain in people who have run out of other options, though the evidence is still limited and it is not a standard treatment. (Emerging area; conclusions are preliminary.)

Looks at using ketamine for severe headache in the emergency room, relevant for patients who end up in the ER during an attack they cannot control. Across all five cases, nebulized ketamine provided significant pain reduction from baseline up to 120 minutes with minimal, self-limited side effects such as mild dizziness, fatigue, or mood changes.

Reference ID: TRT12 (2019)
Reviews how ketamine is being used for headache and concludes it may help difficult cases, but more research is needed before it can be recommended broadly. (Emerging area.)

Neurostimulation & procedures

Reference ID: TRT1 (2016)
Vagus Nerve Stimulation: A handheld device that stimulates a nerve in the neck reduced attacks for some people without surgery or medication, making it a useful add-on option, especially for those who cannot tolerate certain drugs.

Reference ID: TRT2 (2016)
Vagus Nerve Stimulation 2: Further study of the same neck-stimulation device, supporting that it can help reduce attacks for some patients as part of a broader plan.

Reference ID: TRT3 (2010)
Deep Brain Stimulation: A surgical treatment that places an electrode deep in the brain helped some people with the most severe, treatment-resistant chronic cluster headache. It is a serious, last-resort option reserved for the hardest cases.

Reference ID: TRT37 (2009)
Neurostimulation Approaches: An overview of the various nerve- and brain-stimulation options, from simple handheld devices to implanted ones, and where each tends to fit in treatment.

Reference ID: TRT8 (2002)
Hyperbaric Oxygen Studies:  Looked at oxygen delivered in a pressurized chamber and found the evidence too thin to recommend it.

Cluster headache in Pediatrics

Reference ID: PC1 (2010)
Diagnosis and Management of Pediatrice: This article provides a comprehensive overview of non-pharmacological and pharmacological strategies for managing primary headaches, including migraine, tension-type headache, and cluster headache, in children and adolescents. It emphasizes tailored treatment plans combining lifestyle modifications, acute and prophylactic medications, behavioural therapies, and multidisciplinary care to improve quality of life and prevent medication overuse.

Reference ID: PC2 (2008) 
Headache in Childhood: Childhood headaches are common and mostly benign, ranging from acute recurrent migraines and tension-type headaches to rare secondary causes related to increased intracranial pressure. Proper clinical evaluation, reassurance, identification of triggers, and appropriate acute or prophylactic management are essential for effective treatment.

Reference ID: PC3 (2016) 
Pediatric Headache in the ER: Headaches in children are a common emergency department presentation stemming from diverse primary and secondary etiologies, the majority of which are benign and self-limited. Emergency clinicians must rely on a thorough medical history and physical examination to identify potential life-threatening conditions, reserving neuroimaging for cases with abnormal neurological findings or high-risk features.

Reference ID: PC4 (2015)
Integrative Medicine in Pediatrics: The Pediatric Integrative Medicine in Residency (PIMR) program is a 100-hour online educational curriculum developed to address the training gap in pediatric integrative medicine. Preliminary findings indicate that while incoming residents have limited prior exposure and pre-existing knowledge, they demonstrate strong interest in learning and applying integrative medicine in their future practices.

Reference ID: PC5 (2009)
Pediatric Migraine: Migraine is the primary cause of acute recurrent headaches in children, with diagnosis relying mostly on clinical evaluation and family history. Management includes acute symptom relief using acetaminophen or ibuprofen, alongside prophylactic drugs and nonpharmacological approaches like biofeedback for frequent or severe episodes.

Reference ID: PC6 (2004) 
Pharma Treatment Parameters in Pediatric Headache: This practice parameter reviews evidence on pharmacological treatments for pediatric migraine, finding ibuprofen and sumatriptan nasal spray effective for acute headache management. For preventive therapy, flunarizine is probably effective, though unavailable in the United States, while evidence for most other preventive medications remains insufficient or conflicting

Reference ID: PC7 (2013)
Primary Headache in Children: This systematic review summarizes recent clinical evidence on the acute and preventive pharmacotherapy of pediatric migraine and tension-type headache. It notes that while several treatment options exist, high-quality evidence remains limited, with regulatory approvals restricted to select triptans and flupirtine for acute episodes and no agents approved for pediatric headache prevention.

Reference ID: PC8 (2008) 
Evaluating children and adolescents with headaches requires a thorough medical history and physical and neurological examinations to establish a diagnosis and rule out serious secondary causes such as brain tumors. Routine ancillary diagnostic testing, including laboratory work, EEGs, and neuroimaging, is not indicated when the neurological exam is normal, though neuroimaging should be considered if abnormal findings or concerning historical "red flags" are present.

Reference ID: PC 9 (2007) 
This article provides an overview of unusual primary headache syndromes, trigeminal autonomic cephalalgias, and cranial neuralgias in children and adolescents within the context of the ICHD-2 classification system. It highlights key clinical features, genetic connections, and treatment approaches for variants such as hemiplegic migraine, basilar-type migraine, childhood periodic precursors, and rare neuralgias.